Longevity & Aging
Most Men on Testosterone Therapy Never Got Proper Diagnostic Testing
Only 12% of men prescribed testosterone received guideline-recommended testing, raising safety and efficacy concerns.
Press Release
Jun 15, 2026 0
Results for "Testosterone Replacement Therapy"
20 articles
Longevity & Aging
FDA Advances Testosterone Therapy for Low Libido in Men with Unknown Causes
FDA encourages expanded testosterone therapy trials for men with idiopathic hypogonadism experiencing low libido based on emerging clinical evidence.
Press Release
Apr 17, 2026 0
Nutrition & Diet
Testosterone Gel Stops Dangerous Belly Fat Gain in Older Women After Hip Fracture
A clinical trial found testosterone gel plus exercise prevented visceral fat increases in women over 65 recovering from hip fractures.
Press Release
May 8, 2026 0
Hormones
Hormone Therapy Boosts Weight Loss Drug Results by 35% in Postmenopausal Women
Mayo Clinic study finds combining hormone therapy with tirzepatide leads to dramatically better weight loss outcomes for women over 50.
Press Release
Mar 28, 2026 0
Longevity & Aging
Dual Hormone Therapy Around Surgery Boosts Outcomes in High-Risk Prostate Cancer
A phase 3 trial finds combining two hormone therapies before and after prostate surgery outperforms single hormone therapy in high-risk cases.
Press Release
Jun 1, 2026 0
Longevity & Aging
Menopausal Hormone Therapy Cuts Low Bone Density Risk by 69% in Real-World Study
A 387-woman cohort study found hormone therapy slashed low bone mineral density risk by 69%, with measurably better spine and hip scores.
Press Release
Jun 18, 2026 0
Longevity & Aging
Novel Triple-Agonist Drug Retatrutide Achieves Bariatric Surgery-Level Weight Loss
Phase III trial shows retatrutide cuts body weight up to 28% in 80 weeks, also slashing pain and sleep apnea severity.
Press Release
Jun 8, 2026 0
Longevity & Aging
Black and Asian Women Receive Menopause Hormone Therapy at Half the Rate of White Women
A study of 1.8 million women reveals stark racial gaps in menopause hormone therapy use, with Black women steered toward off-label drugs.
Press Release
May 4, 2026 0
Longevity & Aging
Plasma Exchange Therapy Cuts Biological Age by 2.6 Years in Clinical Trial
A first-of-its-kind trial shows therapeutic plasma exchange plus IVIG reduced biological age by an average of 2.6 years, confirmed by multi-omics analysis.
Press Release
May 23, 2026 0
Longevity & Aging
Perioperative Apalutamide Plus ADT Cuts Metastasis Risk 20% in High-Risk Prostate Cancer
Phase III PROTEUS trial shows adding apalutamide to ADT before and after surgery dramatically improves outcomes in high-risk prostate cancer.
Press Release
Jun 1, 2026 0
Longevity & Aging
Heart Drug Vutrisiran Holds Strong Across Real-World ATTR-CM Patients
New analyses of vutrisiran show consistent benefits in diverse heart amyloidosis patients, with a long-term observational study now underway.
Press Release
May 8, 2026 0
Longevity & Aging
New Drug Combo Boosts Tirzepatide Weight Loss by 4.5% While Targeting Brain and Muscle Health
OrsoBio's mitochondrial drug TLC-6740 added 4.5% more weight loss on top of tirzepatide in a Phase 2a trial, with bonus metabolic and cognitive benefits.
Press Release
Jun 13, 2026 0
Longevity & Aging
New Triple-Receptor Drug Cuts Body Weight by 28% in Phase III Trial
Retatrutide achieves surgical-level weight loss in 80 weeks, plus key updates on T1D screening, GLP-1 risks, and teen diabetes rates.
Press Release
May 27, 2026 0
Longevity & Aging
New Drug Combo Adds 4.5% More Weight Loss on Top of Tirzepatide in Trial
OrsoBio's oral TLC-6740 paired with tirzepatide boosted weight loss by an extra 4.5% in 24 weeks, with gains in insulin sensitivity and liver health.
Press Release
Jun 9, 2026 0
Longevity & Aging
FDA Approves Enhertu for Early-Stage HER2+ Breast Cancer in Curative Settings
Trastuzumab deruxtecan wins two new FDA approvals for early HER2+ breast cancer, showing dramatic survival gains over standard therapy.
Press Release
May 19, 2026 0
Longevity & Aging
New Heart Failure Drug TX45 Completes Phase 2 Enrollment Across 14 Countries
Tectonic Therapeutic enrolls 191 patients in a global trial of TX45, a novel fusion protein targeting a deadly heart-lung condition.
Press Release
Jun 13, 2026 0
Longevity & Aging
CD34+ Stem Cell Therapy Heads to Phase 3 to Repair Hearts After Heart Attack
CellProthera's ProtheraCytes targets heart repair post-myocardial infarction, aiming to prevent heart failure before damage becomes irreversible.
Press Release
Jun 3, 2026 0
Longevity & Aging
Darolutamide Plus ADT Cuts Prostate Cancer Progression Risk by 71% in US Trial
A US phase II trial confirms darolutamide combined with ADT dramatically improves survival in metastatic hormone-sensitive prostate cancer.
Press Release
May 19, 2026 0
Longevity & Aging
Gene Therapy PST-611 Shows Early Promise Against Dry AMD in Phase 1 Trial
PulseSight's iron-regulating gene therapy slowed geographic atrophy growth in a first-in-human trial, with Phase 2 planned for 2026.
Press Release
May 13, 2026 0
Longevity & Aging
FDA Approves Teplizumab to Preserve Insulin Production in Kids With New-Onset Type 1 Diabetes
Tzield becomes the first FDA-approved disease-modifying therapy for recently diagnosed Stage 3 type 1 diabetes in pediatric patients ages 8–17.
Press Release
Jun 16, 2026 0
Page 1 of 2Next